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The ability to produce antibodies against the alpha  1-6  epitope of dextran 
B512 is determined by several genes. One (or several linked) gene(s) is located 
in the chromosome coding for the heavy chain of immunoglobulins and deter- 
mines the ability of mice to produce antibodies against the alpha 1-6 epitope of 
dextran (4). This Igh-V gene is present in CBA, C57BL/10, and C57BL/6 mice, 
but is lacking in several other strains not having the Igh-C allotypes j  and b. In 
another strain (CBA/N) an X-linked gene codes for the inability of this strain to 
mount immune responses against thymus-independent (TI) 1 antigens of type II, 
such as  ficoll and  dextran  (5,  14,  15). The  CBA/N  mice possess  the  Igh-C- 
linked V  gene coding for antibodies against the alpha  1-6  epitope of dextran 
(5),  but appear to lack the B cell subpopulation that can be activated by TI lI 
antigens or they lack a gene determining a  B cell-activating receptor for TIII 
antigens (14,  15). 
A substrain of C57BL, namely C57BL/10ScCr, has been found to be a  low 
responder strain to lipopolysaccharide (LPS) and purified protein derivative of 
tuberculin (PPD)  (2).  Since C57BL/10 mice possess  the Igh-C-linked V  gene 
coding for antibodies against the alpha 1-6 epitope of dextran, it was expected 
that  C57BL/10ScCr  mice should also  be  able  to  produce  antibodies against 
dextran. However, neither thymus-dependent nor thymus-independent forms of 
dextran could induce good antidextran responses in this substrain. We have now 
analyzed the mechanism responsible for this low response to dextran. 
Materials and Methods 
Mice.  The inbred mouse strains C57BL/10, CBA, and A have been bred in our mouse 
colony since  1967. The C57BL/10ScCr strain  was obtained from Bomholtgaard,  Ry, 
Denmark  in  1980 and has since been maintained in our department by brother sister 
matings. 
Preparation of Cell Suspensions.  Spleens  were removed and teased with forceps in ice- 
cold balanced salt solution (BSS). After brief sedimentation,  the cells in the supernatant 
were washed three times in 50 ml of cold BSS and then suspended  to the desired  cell 
concentration. Cellular viability was determined in a hemocytometer after the damaged 
* Present address: Dept. of Cell Research, Wallenberglaboratory,  Box 562, S-751 22 Uppsala, 
Sweden. 
l Abbreviations used in this paper: BSA, bovine serum albumin; BSS, balanced salt solution; DNP, 
dinitrophenyl; HRBC, horse erythrocyte;  i.v., intravenously; LPS, lipopolysaccharide;  PBA, poly- 
clonal B cell activator; PFC, plaque-forming  cells; PPD, purified protein derivative of tuberculin; 
SRBC, sheep erythrocyte;  TI, thymus-independent;  TNP, trinitrobenzenesulphonic. 
66  J. Exp. MED. © The Rockefeller  University  Press • 0022-1007/83/07/0066/08  $1.00 
Volume 158  July  1983  66-73 FERNANDEZ  AND  MOLLER  67 
cells had been stained with 0.02% trypan blue. 
Antigens and Immunizations.  Native dextran from Leuconostoc mesenteroides B512, 
average molecular weight 40-100 x  106 daltons, was purchased from ICN Pharmaceuti- 
cals, Cleveland, OH. The mice were immunized with 10 #g ofdextran given intravenously. 
In addition, nonimmunogenic dextran tool wt 40,000 was conjugated to bovine serum 
albumin (BSA-dextran).  This antigen  was prepared as described before and its thymus 
dependence has been documented elsewhere (13).  Mice were immunized intravenously 
(i.v.) with 80 #g of this antigen. Native dinitrophenyl (DNP) dextran was synthesized from 
native dextran by reacting it with N-epsilon-DNP-L-lysine HCL, using the method of Ax~n 
et al. (1). Finally horse erythrocytes cells (HRBC) or sheep erythrocytes (SRBC) were used 
as a  10% solution. The mice were given red cells i.v. in a volume of 0.1  ml. 
Assay of Antibody Synthesis.  Anti-alpha  1-6 plaque-forming cells (PFC) were detected 
by a  direct assay using  SRBC  sensitized  with  stearoyl dextran  B512  with a  molecular 
weight of 70,000, as described before by Howard and co-workers (3). To detect anti-DNP 
PFC, trinitrobenzenesulphonic acid (TNP) was conjugated to SRBC. 
In addition,  indirect  (IgG) PFC  were developed as described  elsewhere (8)  using a 
rabbit anti-mouse immunoglobulin antiserum. In some experiments the protein A plaque 
assay was used, as described by Gronowicz et al. (12). 
Detection of Antiidiotypic  Antibodies.  Sera  from dextran  immunized  (10  #g  of native 
dextran B512) mice were pooled 8 or more days after immunization. The sera were used 
after absorption with an equal volume of packed Sephadex G-75 in the cold over night to 
remove antidextran antibodies.  The efficiency of absorption was verified by the disap- 
pearance  of antidextran  hemolytic antibodies  as  well  as  in  a  radioimmunoassay.  The 
absorbed serum was assayed for its ability to suppress plaque-forming cells against dextran 
or HRBC by adding them in a final dilution of 1/1,000 to a plaque assay using dextran 
coated SRBC and HRBC as targets. The spleen cells used in the plaque assay were derived 
from mice that were immunized against dextran and HRBC 5 d earlier. The assays were 
done in duplicates. 
Mitogens.  Lipopolysaccharide from Escherichia coIi O55:B5  was prepared by phenol- 
water extraction and  was  obtained  from  Dr.  T.  Holme,  Department  of Bacteriology, 
Karolinska Institute, Stockholm. 
Dextran-sulphate was purchased from Pharmacia, Uppsala, Sweden and had a moi wt 
of 5 x  105. The conjugate had a sulphur content of 17% corresponding to an average of 
2.3 sulphate groups per glucosyl residue and a nitrogen content lower than 0.001%. 
Concanavalin A was obtained from Pharmacia, Uppsala, Sweden. 
Culture  Conditions.  Spleen  cells  were  cultured  in  two  different  systems, both  using 
RPMI medium in the absence of serum. Induction of polyclonal antibody synthesis was 
performed in 3-cm-diameter plastic Petri dishes (Nunc, Denmark) with a cell concentration 
of 107 cells/ml per culture in 1-ml cultures, set up in triplicates. Cultures were incubated 
at 37°C in plastic boxes filled with a mixture of 10% CO2, 83% N2, and 7% 02. 
Induction of DNA synthesis was performed in Micro Test II tissue culture plates (no. 
3040;  Falcon Plastics, Oxnard,  CA) with a cell concentration of 106 cells/ml in 0.2  ml 
cultures.  These cultures were incubated in the same conditions as above. All  mitogens 
were dissolved in the same medium as that used for culturing the cells. 
Assay  of DNA  Synthesis.  Cultures  were  given  a  24-h  pulse  of [SH]thymidine  (The 
Radiochemicai Centre, Amersham, England) with a specific activity of 5 Ci/mM, diluted 
in culture medium for a concentration of 2 ~tCi/ml in the cultures.  Microcultures were 
harvested by means of a  multiple cell culture  harvester (Flow  Laboratories, Scotland), 
washing each culture ~  10 ml of cold distilled water. 
Results 
As can be seen in Table I both CBA and C57BL/10  mice gave a good response 
to  the  thymus-independent  antigen  native  dextran  B512,  whereas  C57BL/ 
10ScCr gave a  very poor response. One necessary prerequisite  for B cells to be 
activated  by  a  thymus-independent  antigen  is  that  they  can  respond  to  the 68  MECHANISM  OF  UNRESPONSIVENESS 
TABLE  I 
Low Antibody Response Against Native Dextran in C57BL/ lOScCr 
Mice* 
Strain  No. ofmice  IgM PFC/spleen 
C57BL/10ScCr  37  16.453 ± 2.586 
C57BL/10  15  124.053 ± 21.262 
CBA  13  72.492 ±  13.106 
* Mice older than 3 mo were immunized with  10 #g native dextran i.v. 
The PFC response was determined 5 d later. 
TABLE  II 
Both Thymus-independent and Thymus-dependent Forms of Dextran Fail to Induce a Strong 
Immune Response in C57BL/10ScCr* 
PFC against dextran after immunization  with: 
Strain  BSA-dextran  Native dextran 
IgM  IgG + IgM  IgM  IgG + IgM 
C57BL/10ScCr  960 +  197  27 +  13  3.387 _  795  173 4- 74 
CBA  9.533 + 3.687  3.042 4- 2.042  23.040 4- 6.400  15.946 +_ 6.676 
C57BL/10  26.667 4- 8.030  68.480 ±  18.560  48.213 ±  14.675  131.328 4- 27.500 
* The mice were immunized i.v. with 10 tLg native dextran, I00 ug edestin-dextran, or 80 t~g BSA- 
dextran and the immune response determined 5 d later. 
TABLE  III 
Induction of Polyclonal Antibody Synthesis in Lymphocytes  from C57BL/10 and C57BL/10ScCr 
Mice by Different PBA's* 
Polyclonal B cell activa-  Dose  tor 
IgM PFC with cells from: 
C57BL/10  C57BL/10ScCr 
Exp. 1  Exp. 2  Exp. 1  Exp. 2 
t~g/ml 
--  20.267  79.350  3.067  4.480 
LPS  100  130.130  158.720  5.000  19.840 
Dextran  10.000  142.933  189.440  54.400  116.480 
Dextran-sulphate  100  99.200  116.480  34.133  53.760 
* Serum-free  cultures were used containing l0  T cells/ml in 1 ml cultures.  The IgM PFC response 
was determined at day 2 using protein A-coated  SRBC as targets  and a rabbit anti-mouse  lgM 
developing serum. 
activating signal intrinsic to  most  thymus-independent antigens (6).  It  seemed 
possible that B  cells from C57BL/10ScCr  mice could lack activating receptors 
for dextran.  If so  they would respond to thymus-dependent forms of dextran, 
which activate another B  cell subpopulation than thymus-independent antigens 
(13).  For this purpose, nonimmunogenic forms of dextran (40,000 mol wt) was 
conjugated to BSA and used as an immunogen. As can be seen in Table II, the 
thymus-independent antigen  induced an  even  smaller  IgM  and  IgG  immune 
response  than did  native dextran.  CBA  and  C57BL/10  mice both  gave  good 
IgM responses, whereas only C57BL/10  mice exhibited IgG antibodies. 
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TABLE  IV 
Induction of DNA Synthesis in Lymphocytes  from C57BL/ IO and C57BL/ IOScCr Mice by 
Different Mitogens* 
Mitogen  Dose 
added 
[3H]Thymidineincorporation(cpm) withcells ~om: 
C57BL/10  C57BL/10ScCr 
Exp.  l  Exp. 2  Exp.  1  Exp. 2 
tag/ml 
--  --  14.049--.7.885  12.677+886  2.113_+218 
LPS  100  62.540 4- 2.691  56.433 -  1.976  7.023 _+ 1.419 
Dextran  10.000  31.267 -4- 1.409  41.130 +  1.986  21.445 _+ 414 
Dextran sul-  100  83.113 _+ 5.835  44.152 _+ 504  55.469 _+ 4.993 
phate 
Con A  0.5  55.914 +  4.994  94.384 _+ 9.637  44.780 _+ 6.646 
3.893 +  439 
16.588 +  2.190 
20.725 +  1.005 
14.555 _+ 433 
65.228 "4- 8.191 
* Serum free cultures containing 5  X  105 cells/well were used. [SH]Thymidine was added between 
day  1 and 2. 
TABLE  V 
Anti-TNP Response in Normal and T X B Mice After Immunization with TNP-Dextran* 
Strain  T  X B* 
Anti-TNP PFC of the indicated affinities~ 
High  Medium  Low 
C57BL/10  -  26.560 ___ 6.000  58.720 +  8.915  65.440 -+ 10.360 
C57BL/10ScCr  -  30.827 +_ 9.539  58.240 -+ 11.270  44.480 _+ 12.470 
C57BL/10ScCr  +  36.320 _+ 10.090  65.120 _  17.920  58.240 _  15.819 
* Three mice/group were immunized i.v. with  100 t~g DNP-dextran and the direct PFC response 
tested 5 d  later. 
* T  x  B =  thymectornized, lethally irradiated mice reconstituted with anti-them-treated bone marrow 
cells. 
The affinities were measured by the use of target red cells conjugated with 0.31  #g/ml for high, 
1.25 #g/ml for medium 2.5 #g/ml of TNP for low affinity PFC. 
TABLE  VI 
Antidextran and Anti-HRBC Response in Lethally Irradiated and Bone 
Marrow Reconstituted Chimeras* 
Chimera 
Direct PFC response/spleen against: 
Dextran  HRBC* 
C57BL/10ScCr into C57BL/10 
C57BL/10ScCr into C57BL/10ScCr 
C57BL/10 into C57BL/10 
C57BL/10 into C57BL/l 0ScCr 
7.296 +  2.074  50.624 
12.032 _  2.030  70.784 
34.304 __ 10.497  61.312 
37.504 4- 8.155  55.040 
* Five mice per group were immunized with 10 t~g of native dextran mixed with 
HRBC and their direct PFC response determined 5 d  later. The mice had 3 
mo earlier been lethally irradiated and repopulated with 2 x  106 bone marrow 
cells of the indicated origin. 
* The responses against HRBC were made with pooled suspension of spleen cells. 
(PBA).  One  mechanism  responsible  for  the  failure  of  B  cells  to  respond  to 
certain  antigens  is that  they  lack receptors  for different  PBA  (5,  17).  In order  to 
test whether  this was the  case with B  cells from  C57BL/10ScCr  mice, they  were 
activated  in vitro  with  dextran  and  other  PBA's.  In addition,  mice  were  injected 7O  MECHANISM OF  UNRESPONSIVENESS 
TABLE  VII 
C57BL  /10ScCr Mice Possess the Igh-V Gene Coding  for Antibodies 
Against the Alpha 1-6 Epitope of Dextran, since (A × C57BL/ 
IOScCr)F~ Hybrids are Responders to Dextran 
Mice  No. of mice  IgM PFC against dextran 
A  3  5.973 + 5.335 
(A x C57BL/10)F~  3  55.133 +_ 16.722 
C57BL/10  3  42.133 + 9.432 
C57BL/10ScCr  3  7.200 +- 2.818 
CBA  3  102.806 + 18.778 
(A × C57BL/10ScCr)F~  3  50.773 +- 20.607 
* The mice were immunized with 10 ~g of native dextran i.v. and tested 
for direct antidextran PFC on day 5. 
TABLE  VIII 
The Antidextran PFC Produced by (A x  C57BL/10ScCr)F1 Hybrids Share an Idiotype with PFC 
from High Responder C57BL/ IO Mice 
Percent inhibition of PFC from the indicated strains after addi- 
tion of auto-antiidiotypic serum* 
Auto-antiidiotypic  Serum  dilu- 
(A x  serum donor strain  tion  (A x  C57BL/  CBA  C57BL/ 
C57BL/  C57BL/10  10ScCr 
10)Fl  10ScCr)F1 
CBA  1/1,000  0  10  0  39  10 
C57BL/10  1  / 1,000  38  50  0  3  36 
* Auto-antiidiotypic serum obtained  14  d  after  immunization with dextran  was  absorbed  with 
Sephadex G-75 to remove antidextran antibodies and added to the plaque assay in a final dilution 
of 1/I,000. The cells used in the plaque assay were derived from mice immunized with dextran 5 
d earlier. 
with DNP-dextran and their anti-TNP response tested. In this case, the activation 
signal  for TNP  specific B  cells  is  delivered by the  dextran  carrier.  Therefore, 
the  latter  system  also  tests  for the  presence  of B  cell  activation  receptors  for 
dextran. 
Dextran was found to activate antibody synthesis (Table III) and DNA synthesis 
(Table IV) in lymphocytes from both C57BL/10 and C57BL/10ScCr mice. The 
response  was  lower  than  with  C57BL/10  cells,  but  the  background was  also 
lower.  LPS induced a  low response in lymphocytes from C57BL/10ScCr mice, 
as reported before (2). Both strains responded to dextran sulphate, a PBA known 
to require macrophages and T  cells for optimal B cell activation (10,  16). 
The response to TNP after immunization with DNP-dextran was the same in 
C57BL/10  and  C57BL/10ScCr  mice  (Table  V).  Therefore,  C57BL/10ScCr 
mice do not lack the PBA receptor for dextran or the B cell population responsive 
to activation signals delivered by dextran. 
Lymphocytes from C57BL/ lOScCr Fail to Respond in Irradiated  C57BL/ lO Recipi- 
ents.  It seemed possible that lymphocytes from C57BL/10ScCr were prevented 
from responding to dextran,  because they were actively suppressed  by cells or 
environmental factors present in C57BL/10ScCr mice. Therefore, bone marrow 
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ated C57BL/10,  and, as a  control into C57BL/10ScCr  mice. Other controls 
included  bone  marrow  cells  from  C57BL/10  mice  transferred  into  lethally 
irradiated C57BL/10ScCr  and C57BL/10  recipients, respectively. 3  mo after 
repopulation the mice were immunized with native dextran together with HRBC. 
As can be seen in Table VI  C57BL/10ScCr  cells transferred into C57BL/10 
recipients still failed to respond to dextran, whereas C57BL/10 cells responded 
to  dextran  both  in  syngeneic  and  C57BL/10ScCr  recipients.  All  recipients 
responded equally well to HRBC in any recipient. 
Complementation of the Response to Dextran in Fl Hybrids between C57BL/ lO ScCr 
and A Mice.  C57BL/10ScCr is expected to possess the Igh-V gene coding for 
antibodies  against  dextran,  since  other  C57BL/10  and  C57BL/6  substrains 
express this gene (4). However, we tested whether this was the case by immunizing 
(A x  C57BL/10ScCr)F1  hybrids with dextran. In this hybrid, strain A does not 
possess (or does not express) the antidextran Igh-V gene and cannot produce 
antibodies against dextran (5).  If the hybrid responds, the Igh-V gene against 
dextran must come from the C57BL/10ScCr hap|otype. As can be seen in Table 
VII, this F~ hybrid responded well to dextran. 
The Antidextran PFC Produced by (A × C57BL/ lOScCr)F~ Hybrids Share Idiotype 
with PFC from High Responder C57BL/lO Mice.  The ability of (A  ×  C57BL/ 
10ScCr)F1  hybrids to  respond to  dextran does not  necessarily imply that  the 
same Igh-V gene is expressed in these hybrids and high responder C57BL/10 
mice. In order to test this, we suppressed the antidextran PFC by adding auto- 
antiidiotypic antibodies obtained from CBA and C57BL/10  mice, respectively 
to the PFC assay. We have shown before (9, 11) that auto-antiidiotypic antibodies 
appear spontaneously during the immune response to dextran. CBA mice pro- 
duce auto-antiidiotypic antibodies that suppress PFC from CBA, but not from 
C57BL/10 mice, and the reverse. 
Auto-antiidiotypic sera from CBA and C57BL/10  mice were collected 14 d 
after  a  primary  antidextran  response  and  absorbed  with  Sephadex  G-75  to 
remove antidextran antibodies. The auto-antiidiotypic sera were then added to 
a  plaque  assay  using  spleen  cells  from  mice  immunized against  dextran  5  d 
earlier. As can be seen in  Table VIII, auto-antiidiotypic sera from CBA mice 
suppressed  antidextran  PFC  from  CBA,  but  not  from  C57BL/10  or  (A  × 
C57BL/10ScCr)F1  mice, whereas auto-antiidiotypic sera from the latter showed 
the  reverse  pattern.  Thus,  antidextran  PFC  from  C57BL/10  and  C57BL/ 
10ScCr mice share a common idiotype. 
Discussion 
The low responsiveness of C57BL/10ScCr  mice to dextran was not due to 
lack of PBA receptors for dextran, since native dextran induced polyclonal B 
cell activation and DNP-dextran was a  good immunogen for induction of anti- 
TNP antibodies. Furthermore, the Igh-C-linked dextran V gene was expressed 
in C57BL/10ScCr mice, since the Fl hybrids (A x  C57BL/10ScCr)  responded 
well to dextran. In this hybrid the V gene coding for antibodies against dextran 
comes from the C57BL/10ScCr haplotype, since A mice lack (or do not express) 
the dextran  Igh-V gene. In addition,  the antidextran  PFC produced in  (A  x 
C57BL/10ScCr)F1  hybrids and C57BL/10 mice shared a common idiotype. In 72  MECHANISM OF  UNRESPONSIVENESS 
addition, low responsiveness to dextran seems to be a property of the C57BL/ 
10ScCr lymphocytes, since transfer into irradiated high responder recipients did 
not alter the response. Finally, tolerance can also be discarded as the mechanism 
of unresponsiveness of C57BL/10ScCr  mice, since bone marrow lymphocytes 
from C57BL/10  mice were not prevented from responding to dextran when 
transferred into C57BL/10ScCr mice. 
The  low  response  to  dextran  that  was  observed  in  C57BL/10ScCr  mice 
appears to be different from that of high responder C57BL/10 mice, since the 
antidextran PFC produced by lymphocytes from C57BL/10ScCr mice were not 
suppressed by auto-antiidiotypic antibodies from C57BL/10 mice. 
Since dextran was a  good carrier for the induction of anti-TNP responses in 
C57BL/10ScCr mice, the defective response was not due to a general inability 
to produce antibodies against TIII antigens, as is the case with B cells from the 
CBA/N  strain.  Therefore,  it  seems as  the  low  responsiveness to  dextran  of 
C57BL/10ScCr mice is caused by a determinant specific defect. Such a situation 
has been observed before using dextran as an immunogen. Thus, the very late 
ontogenic  development  of immunocompetence against  dextran  (7)  and  the 
inability  of CBA  mice  to  produce  IgG  antibodies  against  dextran  (8)  both 
specifically affected the alpha  1-6  epitope of dextran and not other epitopes 
conjugated to dextran as a carrier. 
The exact nature of this determinant specific immune defect against the alpha 
1-6 epitope of dextran in C57BL/10ScCr mice remains unknown, but suggests 
the existence of as yet unknown regulatory influences of Igh-V gene expression 
on B cell activation. 
Summary 
C57BL/10ScCr mice are low responders to the alpha  1-6 epitope of dextran 
B512, although other C57BL mice are high responders. Both thymus-independ- 
ent and thymus-dependent forms of dextran failed to induce an immune response 
in C57BL/10ScCr mice, but dextran functioned as a good carrier for antihapten 
responses in this strain.  Dextran is a potent polyclonal B cell activator for cells 
from C57BL/10ScCr  mice, although such cells are not activated by LPS. The 
C57BL/10ScCr  mice  possess  the  Igh-V  gene  coding  for  antibodies  against 
dextran  and  the  antidextran  antibodies  induced  in  (A  x  C57BL/10ScCr)FI 
hybrids share an idiotype with antidextran antibodies produced in C57BL/10 
mice. Bone marrow cells from C57BL/10ScCr mice do not respond to dextran 
when transferred into lethally irradiated C57BL/10  mice and C57BL/10  cells 
transferred into C57BL/10ScCr mice give a strong antidextran response. 
Thus, B cells having both the Igh-V gene coding for antibodies against dextran 
and activation receptors for dextran cannot be activated into antibody synthesis 
against any form of this  immunogen. This determinant specific immunodefi- 
ciency suggests the existence of as yet unknown regulatory influences on Igh-V 
gene expression or B cell activation. 
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